ITPR1 and amyotrophic lateral sclerosis: ITPR2 mRNA levels are elevated in peripheral blood samples of patients with ALS [72] and studies done in human cells suggest that the pharmacological inhibition of ITPR1 is a potential strategy to prevent motor neuron deterioration in ALS [73].